Companies
Analysts Provide An Important Insights On Akebia Therapeutics Inc. (AKBA)
Akebia Therapeutics Inc. (NASDAQ:AKBA) concluded the trading at $2.04 on Thursday, March 21 with a rise of 5.15% from its closing price on previous day.
Akebia Therapeutics Inc. (NASDAQ:AKBA) concluded the trading at $2.04 on Thursday, March 21 with a rise of 5.15% from its closing price on previous day.
Akebia Therapeutics Inc. (NASDAQ:AKBA) traded at $1.89 at close of the session on Monday, March 18, made an upward move of 11.18% on its previous
Stocks Register is a comprehensive online news hub delivering daily updates on various facets of U.S. life, including business, technology, politics, economy, culture, sports, and noteworthy global events.